Prolonged exposure to high and variable phenylalanine levels over the lifetime predicts brain white matter integrity in children with phenylketonuria
- PMID: 25481106
- PMCID: PMC4277899
- DOI: 10.1016/j.ymgme.2014.11.007
Prolonged exposure to high and variable phenylalanine levels over the lifetime predicts brain white matter integrity in children with phenylketonuria
Abstract
In this study, we retrospectively examined the microstructural white matter integrity of children with early- and continuously-treated PKU (N=36) in relation to multiple indices of phenylalanine (Phe) control over the lifetime. White matter integrity was assessed using mean diffusivity (MD) from diffusion tensor imaging (DTI). Eight lifetime indices of Phe control were computed to reflect average Phe (mean, index of dietary control), variability in Phe (standard deviation, standard error of estimate, % spikes), change in Phe with age (slope), and prolonged exposure to Phe (mean exposure, standard deviation exposure). Of these indices, mean Phe, mean exposure, and standard deviation exposure were the most powerful predictors of widespread microstructural white matter integrity compromise. Findings from the two previously unexamined exposure indices reflected the accumulative effects of elevations and variability in Phe. Given that prolonged exposure to elevated and variable Phe was particularly detrimental to white matter integrity, Phe should be carefully monitored and controlled throughout childhood, without liberalization of Phe control as children with PKU age.
Keywords: Brain; Diffusion tensor imaging; Exposure; Phenylalanine; Phenylketonuria; White matter.
Copyright © 2014 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Diffusivity alterations related to cognitive performance and phenylalanine levels in early-treated adults with phenylketonuria.J Neurodev Disord. 2025 Jul 2;17(1):37. doi: 10.1186/s11689-025-09622-8. J Neurodev Disord. 2025. PMID: 40604374 Free PMC article.
-
White matter integrity and executive abilities in individuals with phenylketonuria.Mol Genet Metab. 2013 Jun;109(2):125-31. doi: 10.1016/j.ymgme.2013.03.020. Epub 2013 Apr 6. Mol Genet Metab. 2013. PMID: 23608077 Free PMC article.
-
Stability of blood phenylalanine levels and IQ in children with phenylketonuria.Mol Genet Metab. 2008 Sep-Oct;95(1-2):17-20. doi: 10.1016/j.ymgme.2008.06.014. Epub 2008 Aug 13. Mol Genet Metab. 2008. PMID: 18703366
-
White matter pathology in phenylketonuria.Mol Genet Metab. 2010;99 Suppl 1:S3-9. doi: 10.1016/j.ymgme.2009.10.005. Mol Genet Metab. 2010. PMID: 20123467 Review.
-
White matter disturbances in phenylketonuria: Possible underlying mechanisms.J Neurosci Res. 2021 Jan;99(1):349-360. doi: 10.1002/jnr.24598. Epub 2020 Mar 6. J Neurosci Res. 2021. PMID: 32141105 Review.
Cited by
-
Biochemical markers and neuropsychological functioning in distal urea cycle disorders.J Inherit Metab Dis. 2018 Jul;41(4):657-667. doi: 10.1007/s10545-017-0132-5. Epub 2018 Feb 8. J Inherit Metab Dis. 2018. PMID: 29423830 Free PMC article.
-
Volumetric brain reductions in adult patients with phenylketonuria and their relationship with blood phenylalanine levels.J Neurodev Disord. 2024 Jun 21;16(1):33. doi: 10.1186/s11689-024-09553-w. J Neurodev Disord. 2024. PMID: 38907189 Free PMC article.
-
Serum glial fibrillary acidic protein and neurofilament light chain in patients with early treated phenylketonuria.Front Neurol. 2022 Sep 29;13:1011470. doi: 10.3389/fneur.2022.1011470. eCollection 2022. Front Neurol. 2022. PMID: 36247773 Free PMC article.
-
Effect of dietary regime on metabolic control in phenylketonuria: Is exact calculation of phenylalanine intake really necessary?Mol Genet Metab Rep. 2015 Oct 22;5:36-41. doi: 10.1016/j.ymgmr.2015.09.006. eCollection 2015 Dec. Mol Genet Metab Rep. 2015. PMID: 28649540 Free PMC article.
-
Relationship between age and white matter integrity in children with phenylketonuria.Mol Genet Metab Rep. 2016 Apr 8;7:45-9. doi: 10.1016/j.ymgmr.2016.03.003. eCollection 2016 Jun. Mol Genet Metab Rep. 2016. PMID: 27114916 Free PMC article.
References
-
- Scriver CR. The PAH gene, phenylketonuria, and a paradigm shift. Hum Mutat. 2007;28:831–845. - PubMed
-
- Paine RS. The variability in manifestations of untreated patients with phenylketonuria (phenylpyruvic aciduria) Pediatrics. 1957;20:290–302. - PubMed
-
- Brumm VL, Grant ML. The role of intelligence in phenylketonuria: a review of research and management. Mol Genet Metab. 2010;99:S18–S21. - PubMed
-
- Christ SE, Huijbregts SCJ, de Sonneville LMJ, White DA. Executive function in early-treated phenylketonuria: Profile and underlying mechanisms. Mol Genet Metab. 2010;99(Supple):S22–S32. - PubMed
-
- Gentile JK, Ten Hoedt AE, Bosch AM. Psychosocial aspects of PKU: hidden disabilities–a review. Mol Genet Metab. 2010;99:S64–S67. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical